CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CX • US1512908898

12.94 USD
0 (0%)
At close: Feb 11, 2026
12.94 USD
0 (0%)
After Hours: 2/11/2026, 6:15:52 PM
Fundamental Rating

4

CX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 13 industry peers in the Construction Materials industry. There are concerns on the financial health of CX while its profitability can be described as average. CX is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CX was profitable.
  • In the past year CX had a positive cash flow from operations.
  • Of the past 5 years CX 4 years were profitable.
  • Of the past 5 years CX 4 years had a positive operating cash flow.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

  • CX has a Return On Assets of 4.70%. This is in the lower half of the industry: CX underperforms 61.54% of its industry peers.
  • Looking at the Return On Equity, with a value of 10.03%, CX is in line with its industry, outperforming 46.15% of the companies in the same industry.
  • With a Return On Invested Capital value of 5.31%, CX is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
  • CX had an Average Return On Invested Capital over the past 3 years of 6.81%. This is below the industry average of 9.09%.
Industry RankSector Rank
ROA 4.7%
ROE 10.03%
ROIC 5.31%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.62%, CX is doing worse than 61.54% of the companies in the same industry.
  • CX's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 9.55%, CX is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of CX has grown nicely.
  • CX has a Gross Margin of 32.75%. This is in the better half of the industry: CX outperforms 69.23% of its industry peers.
  • In the last couple of years the Gross Margin of CX has remained more or less at the same level.
Industry RankSector Rank
OM 9.55%
PM (TTM) 8.62%
GM 32.75%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

  • CX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 1.74, we must say that CX is in the distress zone and has some risk of bankruptcy.
  • CX has a worse Altman-Z score (1.74) than 61.54% of its industry peers.
  • CX has a debt to FCF ratio of 12.73. This is a negative value and a sign of low solvency as CX would need 12.73 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 12.73, CX perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
  • A Debt/Equity ratio of 0.44 indicates that CX is not too dependend on debt financing.
  • CX's Debt to Equity ratio of 0.44 is fine compared to the rest of the industry. CX outperforms 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 12.73
Altman-Z 1.74
ROIC/WACC0.36
WACC14.67%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • CX has a Current Ratio of 0.91. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CX has a Current ratio of 0.91. This is amonst the worse of the industry: CX underperforms 84.62% of its industry peers.
  • A Quick Ratio of 0.67 indicates that CX may have some problems paying its short term obligations.
  • CX has a Quick ratio of 0.67. This is in the lower half of the industry: CX underperforms 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.67
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

  • CX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -85.49%.
  • CX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.77% yearly.
EPS 1Y (TTM)-85.49%
EPS 3Y14.77%
EPS 5YN/A
EPS Q2Q%-433.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.66%

3.2 Future

  • Based on estimates for the next years, CX will show a very strong growth in Earnings Per Share. The EPS will grow by 91.80% on average per year.
  • The Revenue is expected to grow by 5.90% on average over the next years.
EPS Next Y231.07%
EPS Next 2Y91.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.11%
Revenue Next 2Y4.76%
Revenue Next 3Y7.87%
Revenue Next 5Y5.9%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 -4

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 15.40, CX is valued correctly.
  • CX's Price/Earnings ratio is rather cheap when compared to the industry. CX is cheaper than 100.00% of the companies in the same industry.
  • CX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.23.
  • Based on the Price/Forward Earnings ratio of 4.65, the valuation of CX can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of CX to the average of the S&P500 Index (28.01), we can say CX is valued rather cheaply.
Industry RankSector Rank
PE 15.4
Fwd PE 4.65
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CX is valued a bit cheaper than 69.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.2
EV/EBITDA 8.58
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CX's earnings are expected to grow with 91.80% in the coming years.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y91.8%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 20.36%, CX is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.02, CX pays a better dividend. On top of this CX pays more dividend than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.79, CX pays a better dividend.
Industry RankSector Rank
Dividend Yield 20.36%

5.2 History

  • CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • 9.12% of the earnings are spent on dividend by CX. This is a low number and sustainable payout ratio.
DP9.12%
EPS Next 2Y91.8%
EPS Next 3YN/A
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B
CX Dividend Payout.CX Dividend Payout, showing the Payout Ratio.CX Dividend Payout.PayoutRetained Earnings

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (2/11/2026, 6:15:52 PM)

After market: 12.94 0 (0%)

12.94

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-05
Earnings (Next)04-23
Inst Owners25.28%
Inst Owner Change0.36%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.77B
Revenue(TTM)N/A
Net Income(TTM)1.36B
Analysts78.67
Price Target12.86 (-0.62%)
Short Float %0.74%
Short Ratio1.71
Dividend
Industry RankSector Rank
Dividend Yield 20.36%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP9.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.04%
Min EPS beat(2)-51.46%
Max EPS beat(2)-12.62%
EPS beat(4)0
Avg EPS beat(4)-38.83%
Min EPS beat(4)-88.35%
Max EPS beat(4)-2.91%
EPS beat(8)1
Avg EPS beat(8)144.98%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.88%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-1.61%
Revenue beat(4)0
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)-1.61%
Revenue beat(8)0
Avg Revenue beat(8)-4.48%
Revenue beat(12)1
Avg Revenue beat(12)-3.51%
Revenue beat(16)2
Avg Revenue beat(16)1.69%
PT rev (1m)8.57%
PT rev (3m)22.74%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)-5.18%
Revenue NQ rev (3m)-11.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 15.4
Fwd PE 4.65
P/S 1.19
P/FCF 35.2
P/OCF 9.19
P/B 1.38
P/tB 4.67
EV/EBITDA 8.58
EPS(TTM)0.84
EY6.49%
EPS(NY)2.78
Fwd EY21.49%
FCF(TTM)0.37
FCFY2.84%
OCF(TTM)1.41
OCFY10.88%
SpS10.91
BVpS9.38
TBVpS2.77
PEG (NY)0.07
PEG (5Y)N/A
Graham Number13.31
Profitability
Industry RankSector Rank
ROA 4.7%
ROE 10.03%
ROCE 6.73%
ROIC 5.31%
ROICexc 5.67%
ROICexgc 10.4%
OM 9.55%
PM (TTM) 8.62%
GM 32.75%
FCFM 3.37%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
ROICexc(3y)7.18%
ROICexc(5y)6.61%
ROICexgc(3y)13.44%
ROICexgc(5y)12.5%
ROCE(3y)8.62%
ROCE(5y)7.97%
ROICexgc growth 3Y3.59%
ROICexgc growth 5Y8.98%
ROICexc growth 3Y3.55%
ROICexc growth 5Y10.09%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 12.73
Debt/EBITDA 2.16
Cap/Depr 117.98%
Cap/Sales 9.53%
Interest Coverage 250
Cash Conversion 73.17%
Profit Quality 39.1%
Current Ratio 0.91
Quick Ratio 0.67
Altman-Z 1.74
F-Score5
WACC14.67%
ROIC/WACC0.36
Cap/Depr(3y)98.23%
Cap/Depr(5y)87.02%
Cap/Sales(3y)7.21%
Cap/Sales(5y)6.61%
Profit Quality(3y)217.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.49%
EPS 3Y14.77%
EPS 5YN/A
EPS Q2Q%-433.33%
EPS Next Y231.07%
EPS Next 2Y91.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.66%
Revenue Next Year5.11%
Revenue Next 2Y4.76%
Revenue Next 3Y7.87%
Revenue Next 5Y5.9%
EBIT growth 1Y-29.96%
EBIT growth 3Y2.07%
EBIT growth 5Y6.6%
EBIT Next Year60.32%
EBIT Next 3Y22.39%
EBIT Next 5YN/A
FCF growth 1Y-51.1%
FCF growth 3Y-11.58%
FCF growth 5Y-3.16%
OCF growth 1Y-17.47%
OCF growth 3Y0.91%
OCF growth 5Y6.96%

CEMEX SAB-SPONS ADR PART CER / CX FAQ

What is the ChartMill fundamental rating of CEMEX SAB-SPONS ADR PART CER (CX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CX.


What is the valuation status for CX stock?

ChartMill assigns a valuation rating of 8 / 10 to CEMEX SAB-SPONS ADR PART CER (CX). This can be considered as Undervalued.


What is the profitability of CX stock?

CEMEX SAB-SPONS ADR PART CER (CX) has a profitability rating of 4 / 10.


Can you provide the financial health for CX stock?

The financial health rating of CEMEX SAB-SPONS ADR PART CER (CX) is 2 / 10.


How sustainable is the dividend of CEMEX SAB-SPONS ADR PART CER (CX) stock?

The dividend rating of CEMEX SAB-SPONS ADR PART CER (CX) is 6 / 10 and the dividend payout ratio is 9.12%.